Mark Zucker

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas”.

Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas

European Urology Focus(2022)10.1016/j.euf.2021.12.002

N/A

0.835DataRank · unranked

27 citations

Cerise Tang, Mark Zucker, Kelly N. Fitzgerald, Renzo G. DiNatale, Phillip M. Rappold +15 more

A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.10.017

N/A

0.416DataRank · unranked

15 citations

Sahil D. Doshi, Andrea Knežević, Joshua Chaim, Ying‐Bei Chen, Rachel Jacobi +14 more

Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma

Frontiers in Oncology(2022)10.3389/fonc.2022.910147

N/A

0DataRank · unranked

14 citations

Mark Zucker, Min‐Soo Kim, Paul Russo, Jonathan Coleman, Chung‐Han Lee +6 more

Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.28.489873

N/A

0DataRank · unranked

2 citations

Mark Zucker, Min‐Soo Kim, Paul Russo, Jonathan Coleman, Chung‐Han Lee +6 more